Bioemulsifier Produced by Aspergillus niger UCP 1064 Isolated from Caatinga Soil as a Promising Molecule for Scaled-Up Pharmaceutical Applications

This study presents the production, characterization, and potential pharmaceutical application of a bioemulsifier synthesized by Aspergillus niger UCP 1064 by submerged fermentation using agro-industrial residues (cassava wastewater and soluble starch). The compound exhibited a high emulsification index (EI24 > 88%) against hydrophobic substrates, effectively reduced surface tension, and remained stable across a wide range of pH (2–12), temperatures (5–100 °C), and salinity levels (0–20% NaCl). Microscopic analysis confirmed the formation of stable oil-in-water (O/W) emulsions, while biochemical tests identified the compound as a glycolipoprotein. Rheological assays demonstrated a significant reduction in oil viscosity, enhancing fluidity. Through factorial design and response surface methodology, production conditions were optimized, achieving yields of up to 3.18 g/L. A theoretical scale-up indicated technical feasibility for pharmaceutical applications; however, challenges such as process reproducibility, sterility, and regulatory compliance persist. These findings highlight the bioemulsifier’s potential as a sustainable and biocompatible alternative for drug delivery systems.